OR WAIT null SECS
Technologies to develop and manufacture biopharmaceuticals continue evolving
Technological advances are aiding manufacturers to streamline aseptic processes.
Quality Considerations for Using AI in Bio/Pharma
Sterile filtration and use of sterile single-use materials provide the best solutions depending on vector size.
October 22, 2024
Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics at AAPS PharmSci 360.
October 18, 2024
Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT.
The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.
October 17, 2024
Through the collaboration, Merck will use Mestag’s proprietary RAFT platform to investigate the pathogenic role that fibroblasts play in inflammatory diseases.
The establishment of this new center aims to expedite R&D processes, reduce costs, and potentially lead to accelerated discovery of new candidate therapies.
The new center's design will prioritize integration of the entire supply chain, with the aim of accelerating product development and autonomous production capacity in alignment with EU priorities.
October 12, 2024
SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product.
Evonik's plant-based squalene, PhytoSquene, used in parenteral drug delivery applications, won the CPHI Excellence in Pharma Award in the “Sustainability” category.
October 11, 2024
The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024.
Aseptic fill/finish of biopharmaceuticals requires an understanding of the structure and limitations of each molecule.